Orphan Drugs & Rare Diseases Global Congress 2022 Europe

Attend Orphan Drugs & Rare Diseases 2022

Orphan Drugs & Rare Diseases Global Congress 2022 Europe will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top-tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organizations, orphan drugs developers as well as regional and local manufacturers. Network with 120+ representatives from pharma, biotech, patient groups/advocates, government, CROs, and others…

Who Should Attend!

Pharmaceutical & Biotech 

  • VP Cell,
  • Therapy Head of Oncology
  • Chief Medical Officer
  • Head of Immunotherapy
  • Chief Operations Officer
  • Heads of Discovery
  • VP Clinical Development
  • Chief Medical Officer
  • Chief Scientific Officer
  • Regulatory Affairs
  • President, Head of Rare Diseases
  • VP Clinical Development
  • Chief Medical Officer
  • Chief Scientific Officer
  • Regulatory Affairs
  • President, Head of Rare Diseases
  • VP Gene Therapy
  • Chief Medical Officer
  • Chief Manufacturing Officer
  • Chief Scientific Office
  • Chief Operating Officer
  • Chief Manufacturing &
  • Technology Officer
  • VP Technical Operations
  • VP of CMC
  • VP Manufacturing
  • VP of Process Development
  • VP of Quality Control
  • Presidents & Heads of Patient
  • Diagnosis
  • Programs
  • R&D Strategic Alliance
  • VP Commercial Operations
  • VP Medical Affairs
  • VP of Marketing
  • VP Medical Affairs
  • VP Market Access
  • Pricing and Reimbursement

Pharmaceuticals & Biotech 

  • Chief Commercial Officer
  • International Business
  • Chief Executive Office
  • VP, Head of Market Access
  • VP, Head of Pricing and Reimbursement
  • VP of Health Economics/HEOR
  • VP of HTA
  • Head of Value Demonstration
  • VP, Evidence, and Data
  • Payers (public and private)
  • Government & Regulatory agencies
  • Chief Data Officer
  • Chief Technology Officer
  • Chief Operating Officer
  • VP, Analytics
  • Head of Innovation
  • Head of Digital
  • MAP Providers

Other Participating Attendees Should Include the following.

  • Patient Advocacy Groups
  • Rare Disease advocacy organizations
  • Newborn Screening
  • Hospitals & Healthcare Centers
    Payers
  • Government
  • Policy Makers
  • Ministry of Health
  • Regulators
  • Non Profit Organizations
  • Academics
  • Research Institution

And many more…

Attend Orphan Drugs & Rare Diseases 2022

15th Orphan Drugs & Rare Diseases Global Congress 2021 Europe

Conference Pricing

Early Bird
Standard Rate

2 Day Conference

£1299 / attendee
  • Pre-Conference Workshop
  • 2 Day Conference
  • Continental Breakfast
  • Networking Drinks Reception
  • Gala Dinner

Special Group Discounts: Sign up with your team for even more savings!!!

Patient Groups: Free (Register in advance to guarantee your place)

Scroll to Top